The effects of medications on bone - PubMed (original) (raw)

Review

The effects of medications on bone

Stuart B Goodman et al. J Am Acad Orthop Surg. 2007 Aug.

Abstract

Medications taken for the treatment of arthritis and psychotropic and epileptic disorders, as well as anticoagulants, antacids, bisphosphonates, corticosteroids, and antineoplastic drugs, can profoundly affect bone metabolism. In some scenarios (eg, osteoporosis), these effects are intended; in others (eg, rickets, osteomalacia secondary to antiepileptic drugs), potentially adverse side effects of medications on bone may occur. Nonsteroidal anti-inflammatory drugs appear to delay fracture healing and bone ingrowth, although these effects are reversible. Disease-modifying antirheumatic drugs do not appear to affect bone metabolism adversely when taken in the low dosages currently prescribed. Bisphosphonates are useful in restoring bone mass in cases of postmenopausal osteoporosis, glucocorticoid-induced osteoporosis, Paget's disease, and neoplastic conditions with bone loss and hypercalcemia. Corticosteroids and cancer chemotherapeutic agents generally affect bone adversely and increase fracture risk.

PubMed Disclaimer

Similar articles

• Management of osteoporosis in rheumatoid arthritis patients.
  Hoes JN, Bultink IE, Lems WF. Hoes JN, et al. Expert Opin Pharmacother. 2015 Mar;16(4):559-71. doi: 10.1517/14656566.2015.997709. Epub 2015 Jan 27. Expert Opin Pharmacother. 2015. PMID: 25626121 Review.
• [Glucocorticoid and Bone. Pathogenesis of glucocorticoid-induced osteoporosis].
  Tanaka Y. Tanaka Y. Clin Calcium. 2014 Sep;24(9):1289-94. Clin Calcium. 2014. PMID: 25177000 Review. Japanese.
• Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
  De Nijs RN. De Nijs RN. Minerva Med. 2008 Feb;99(1):23-43. Minerva Med. 2008. PMID: 18299694 Review.
• Aromatase inhibitors and bone.
  Eastell R. Eastell R. J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):157-61. doi: 10.1016/j.jsbmb.2007.05.017. Epub 2007 May 24. J Steroid Biochem Mol Biol. 2007. PMID: 17643293

Cited by

• Bovine Hydroxyapatite-Based Bone Scaffold with Gentamicin Accelerates Vascularization and Remodeling of Bone Defect.
  Budiatin AS, Gani MA, Samirah, Ardianto C, Raharjanti AM, Septiani I, Putri NPKP, Khotib J. Budiatin AS, et al. Int J Biomater. 2021 May 5;2021:5560891. doi: 10.1155/2021/5560891. eCollection 2021. Int J Biomater. 2021. PMID: 34104195 Free PMC article.
• Fifth metatarsal fractures: an update on management, complications, and outcomes.
  Chloros GD, Kakos CD, Tastsidis IK, Giannoudis VP, Panteli M, Giannoudis PV. Chloros GD, et al. EFORT Open Rev. 2022 Jan 11;7(1):13-25. doi: 10.1530/EOR-21-0025. EFORT Open Rev. 2022. PMID: 35073515 Free PMC article. Review.
• Altered Bone Status in Rett Syndrome.
  Pecorelli A, Cordone V, Schiavone ML, Caffarelli C, Cervellati C, Cerbone G, Gonnelli S, Hayek J, Valacchi G. Pecorelli A, et al. Life (Basel). 2021 Jun 3;11(6):521. doi: 10.3390/life11060521. Life (Basel). 2021. PMID: 34205017 Free PMC article. Review.
• Simvastatin induces adverse effects on proliferation and mineralization of human primary osteoblasts.
  Sabandal MMI, Schäfer E, Aed J, Jung S, Kleinheinz J, Sielker S. Sabandal MMI, et al. Head Face Med. 2020 Aug 20;16(1):18. doi: 10.1186/s13005-020-00232-4. Head Face Med. 2020. PMID: 32819403 Free PMC article.
• Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation.
  Pashuck TD, Franz SE, Altman MK, Wasserfall CH, Atkinson MA, Wronski TJ, Flotte TR, Stalvey MS. Pashuck TD, et al. Pediatr Res. 2009 Mar;65(3):311-6. doi: 10.1203/PDR.0b013e3181961e80. Pediatr Res. 2009. PMID: 19047917 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wolters Kluwer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information